Home >
The FDA approval of Mylan’s Semglee as an “interchangeable biosimilar,” for Lantus will allow pharmacies to substitute Semglee for Lantus like any generic drug (subject to state pharmacy laws).
News
<>
July 30, 2021
The FDA approval of Mylan’s Semglee as an “interchangeable biosimilar,” for Lantus will allow pharmacies to substitute Semglee for Lantus like any generic drug (subject to state pharmacy laws).
